BACKGROUND: Most previous studies about anxiety and depression in patients undergoing radiotherapy have only measured the quantity of general depression and anxiety and have not studied specific periods of involvement. The aim of this study was to assess anxiety and depression among early breast cancer patients, and the anxiety experienced immediately before and after radiotherapy. METHODS: Women who started radiotherapy for stage I or II breast cancer (n = 172) were asked to answer two questionnaires: the Hospital Anxiety and Depression Scale (HADS) and Radiotherapy Categorical Anxiety Scale immediately before and after radiation therapy. RESULTS: The results showed that the mean scores of anxiety and depression (HADS and Radiotherapy Categorical Anxiety Scale) decreased after radiotherapy. The mean score of depression (HAD-D) in the group receiving conventional radiotherapy was higher than in those receiving hypofractionated radiotherapy before and after radiotherapy. The mean scores of anxiety and depression (HADS) in the endocrine therapy group were lower than in the group without endocrine therapy before treatment. However, the scores after treatment of both groups were not significant. CONCLUSION: Some intervention may be needed to decrease the temporary anxiety and depression raised during radiotherapy for early stage breast cancer patients. This is especially so for patients who do not receive concurrent endocrine therapy and choose the conventional radiotherapy course.
BACKGROUND: Most previous studies about anxiety and depression in patients undergoing radiotherapy have only measured the quantity of general depression and anxiety and have not studied specific periods of involvement. The aim of this study was to assess anxiety and depression among early breast cancerpatients, and the anxiety experienced immediately before and after radiotherapy. METHODS:Women who started radiotherapy for stage I or II breast cancer (n = 172) were asked to answer two questionnaires: the Hospital Anxiety and Depression Scale (HADS) and Radiotherapy Categorical Anxiety Scale immediately before and after radiation therapy. RESULTS: The results showed that the mean scores of anxiety and depression (HADS and Radiotherapy Categorical Anxiety Scale) decreased after radiotherapy. The mean score of depression (HAD-D) in the group receiving conventional radiotherapy was higher than in those receiving hypofractionated radiotherapy before and after radiotherapy. The mean scores of anxiety and depression (HADS) in the endocrine therapy group were lower than in the group without endocrine therapy before treatment. However, the scores after treatment of both groups were not significant. CONCLUSION: Some intervention may be needed to decrease the temporary anxiety and depression raised during radiotherapy for early stage breast cancerpatients. This is especially so for patients who do not receive concurrent endocrine therapy and choose the conventional radiotherapy course.
Authors: Mylin A Torres; Thaddeus W Pace; Tian Liu; Jennifer C Felger; Donna Mister; Gregory H Doho; Jordan N Kohn; Andrea M Barsevick; Qi Long; Andrew H Miller Journal: Cancer Date: 2013-03-19 Impact factor: 6.860
Authors: Valerio Nardone; Alfonso Reginelli; Claudia Vinciguerra; Pierpaolo Correale; Maria Grazia Calvanese; Sara Falivene; Angelo Sangiovanni; Roberta Grassi; Angela Di Biase; Maria Angela Polifrone; Michele Caraglia; Salvatore Cappabianca; Cesare Guida Journal: Front Psychol Date: 2021-03-19
Authors: Mateusz Grajek; Karolina Krupa-Kotara; Mateusz Rozmiarek; Karolina Sobczyk; Eliza Działach; Michał Górski; Joanna Kobza Journal: Int J Environ Res Public Health Date: 2022-09-10 Impact factor: 4.614